Group One Trading, L.P. Biora Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 09, 2023	BUY	$0.13 - $12.03 $4,664 - $431,600	35,877 New	35,877 $4,000
Q2 2022 Aug 11, 2022	SELL	$0.56 - $1.22 $21,566 - $46,984	-38,512 Reduced 80.73%	9,192 $6,000
Q1 2022 May 12, 2022	BUY	$1.11 - $2.25 $52,951 - $107,334	47,704 New	47,704 $55,000
Q4 2021 Feb 11, 2022	SELL	$1.35 - $4.89 $114,627 - $415,205	-84,909 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$0.67 - $3.41 $38,033 - $193,572	56,766 Added 201.71%	84,909 $129,000
Q2 2021 Aug 10, 2021	BUY	$2.11 - $4.93 $56,313 - $131,576	26,689 Added 1835.56%	28,143 $100,000
Q1 2021 May 12, 2021	BUY	$3.91 - $7.31 $5,685 - $10,628	1,454 New	1,454 $7,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $105M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.